Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001562180-23-004632)

Filing Details

Accession Number:: 0001562180-23-004632
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-05-31 17:22:24
Reporting Period:: 2023-05-30

Accepted Time:: 2023-05-31 17:22:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1314102	Eyepoint Pharmaceuticals Inc.	EYPT	Laboratory Analytical Instruments (3826)	262774444

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1840407	Ye Liu	56F, One Museum Place, 669 Xin Zha Road Jing'An District Shanghai 200041		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	Disposition	2023-05-30	1	$6.00	3,010,721	No	4	S	Indirect	Ocumension Therapeutics

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Ocumension Therapeutics

Footnotes

Sale of one share to test new broker
The shares are held by Ocumension Therapeutics. The reporting person is Chief Executive Officer and a Director of Ocumension Therapeutics. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.